Category: Latest News
-
US takes GDP to blockchains in historic step towards economic transparency
The US government has officially begun publishing economic data on public blockchains, including Bitcoin, Ethereum, and Solana. The Commerce Department’s announcement marks a historic step in bringing Gross Domestic Product (GDP) and other indicators into decentralized, globally accessible networks. The measure does not replace traditional disclosure, but it certainly expands data distribution channels and lends…
-
U.S. Stocks Move Mostly Higher After Early Volatility
After showing a lack of direction early in the session, stocks moved mostly higher over the course of the trading day on Thursday. The major averages added to the gains posted in the two previous sessions, with the S&P 500 reaching another new record closing high. The major averages ended the day just off their…
-
Travere Therapeutics Stock Climbs After FDA Eases FILSPARI Monitoring Requirements
Shares of Travere Therapeutics Inc (NASDAQ:TVTX) jumped 8.8% after the U.S. Food and Drug Administration approved revised monitoring guidelines for its kidney disease therapy FILSPARI. The FDA has reduced the required liver function checks for patients on FILSPARI from monthly to once every three months. Additionally, the agency eliminated the embryo-fetal toxicity monitoring requirement from…
-
Agrify Shares Surge After Acquiring Green Thumb Brand Portfolio
Agrify Corporation (NASDAQ:AGFY) saw its stock leap 50% after the company announced it had purchased a portfolio of brand intellectual properties from Green Thumb Industries for $50 million, funded via a convertible note. The deal includes well-known cannabis brands such as RYTHM, Dogwalkers, and Beboe. Under the agreement, Agrify will license the brands back to…
-
SharkNinja Shares Drop After CFO Patraic Reagan Announces Departure
SharkNinja Inc. (NYSE:SN) saw its stock decline about 5% on Thursday following news that Chief Financial Officer Patraic Reagan will step down, effective September 5, 2025. According to a Securities and Exchange Commission filing, Reagan informed the company of his decision on August 26. SharkNinja stressed that his resignation is unrelated to any disputes or…
-
Caliber Shares Surge as Company Unveils Digital Asset Treasury Plan
CaliberCos Inc (NASDAQ:CWD) stock jumped roughly 80% following the announcement that the company’s Board of Directors has approved a digital asset treasury strategy centered on acquiring LINK tokens, which are used in the Chainlink protocol. Under the new plan, Caliber will allocate part of its treasury to purchase cryptocurrency, with an initial focus on LINK…
-
Snowflake Shares Surge After Q2 Beat and Raised Guidance
Snowflake Inc. (NYSE:SNOW) shares jumped roughly 14% in early trading Thursday after the cloud data platform provider reported second-quarter results that surpassed analyst expectations and increased its full-year product revenue outlook. The company posted $1.14 billion in quarterly revenue, beating the consensus estimate of $1.09 billion and reflecting a 32% year-over-year increase. Product revenue, which…
-
Celcuity Shares Soar After FDA Accepts Gedatolisib NDA for Review
Celcuity Inc. (NASDAQ:CELC) stock jumped 9.3% following the announcement that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gedatolisib in HR+/HER2- advanced breast cancer. The submission will be reviewed under the FDA’s Real-Time Oncology Review (RTOR) program. The RTOR initiative allows companies to submit key efficacy and safety…
-
Teva Shares Rise Following Launch of First Generic GLP-1 Weight Loss Drug
Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) saw its stock climb 2.7% after announcing FDA approval and the U.S. launch of its generic version of Saxenda (liraglutide injection). This marks the first generic GLP-1 drug specifically approved for weight loss. The new liraglutide injection addresses rising demand for weight management therapies in the United States. It…
-
Telomir Shares Surge After Lead Drug Shows Strong Epigenetic Activity
Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw its stock jump 38% following the announcement of encouraging in vitro results for its lead drug candidate, Telomir-1. The data revealed that the compound effectively inhibits UTX (KDM6A), an enzyme long deemed “undruggable” and linked to cancer and aging. The preclinical-stage biotech firm reported that Telomir-1 potently blocks UTX, which…